220 related articles for article (PubMed ID: 19834284)
1. Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB.
Lee SY; Cho JS; Yuk DY; Moon DC; Jung JK; Yoo HS; Lee YM; Han SB; Oh KW; Hong JT
J Pharmacol Sci; 2009 Oct; 111(2):124-36. PubMed ID: 19834284
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-kappaB.
Lee SY; Yuk DY; Song HS; Yoon DY; Jung JK; Moon DC; Lee BS; Hong JT
Eur J Pharmacol; 2008 Mar; 582(1-3):17-25. PubMed ID: 18241858
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
[TBL] [Abstract][Full Text] [Related]
4. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
[TBL] [Abstract][Full Text] [Related]
5. Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B.
Ban JO; Lee HS; Jeong HS; Song S; Hwang BY; Moon DC; Yoon DY; Han SB; Hong JT
Mol Cancer Res; 2009 Jun; 7(6):870-9. PubMed ID: 19531569
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappaB/MAP kinases in lipopolysaccharide-treated RAW 264.7cells.
Choi MS; Lee SH; Cho HS; Kim Y; Yun YP; Jung HY; Jung JK; Lee BC; Pyo HB; Hong JT
Eur J Pharmacol; 2007 Feb; 556(1-3):181-9. PubMed ID: 17134693
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
[TBL] [Abstract][Full Text] [Related]
9. 4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity.
Oh JH; Ban JO; Cho MC; Jo M; Jung JK; Ahn B; Yoon DY; Han SB; Hong JT
J Nutr Biochem; 2012 Jul; 23(7):706-15. PubMed ID: 21820300
[TBL] [Abstract][Full Text] [Related]
10. Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathway.
Choi DY; Lee JW; Lin G; Lee YK; Lee YH; Choi IS; Han SB; Jung JK; Kim YH; Kim KH; Oh KW; Hong JT; Lee MS
Neurochem Int; 2012 Jan; 60(1):68-77. PubMed ID: 22107706
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by obovatol as a novel therapeutic strategy for acute myeloid leukemia.
Kim HS; Lim GY; Hwang J; Ryoo ZY; Huh TL; Lee S
Int J Mol Med; 2014 Dec; 34(6):1675-80. PubMed ID: 25319672
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
[TBL] [Abstract][Full Text] [Related]
13. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells.
Parrondo R; de las Pozas A; Reiner T; Rai P; Perez-Stable C
Mol Cancer; 2010 Jul; 9():182. PubMed ID: 20618955
[TBL] [Abstract][Full Text] [Related]
15. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
16. Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis.
Lee SK; Kim HN; Kang YR; Lee CW; Kim HM; Han DC; Shin J; Bae K; Kwon BM
Bioorg Med Chem; 2008 Sep; 16(18):8397-402. PubMed ID: 18762427
[TBL] [Abstract][Full Text] [Related]
17. γ-tocotrienol enhances the chemosensitivity of human oral cancer cells to docetaxel through the downregulation of the expression of NF-κB-regulated anti-apoptotic gene products.
Kani K; Momota Y; Harada M; Yamamura Y; Aota K; Yamanoi T; Takano H; Motegi K; Azuma M
Int J Oncol; 2013 Jan; 42(1):75-82. PubMed ID: 23138939
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells.
Nakahara C; Nakamura K; Yamanaka N; Baba E; Wada M; Matsunaga H; Noshiro H; Tanaka M; Morisaki T; Katano M
Clin Cancer Res; 2003 Nov; 9(14):5409-16. PubMed ID: 14614027
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of obovatol on osteoclast differentiation and bone resorption.
Kim HJ; Hong JM; Yoon HJ; Kwon BM; Choi JY; Lee IK; Kim SY
Eur J Pharmacol; 2014 Jan; 723():473-80. PubMed ID: 24334279
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B.
Zheng J; Lee HL; Ham YW; Song HS; Song MJ; Hong JT
Oncotarget; 2015 Dec; 6(42):44437-51. PubMed ID: 26561202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
